Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Apex Critical Metals Reports Widened Loss Amid Accelerated Exploration Drive

Dieter Jaworski by Dieter Jaworski
December 22, 2025
in Commodities, Earnings, Penny Stocks
0
Apex Critical Metals Stock
0
SHARES
21
VIEWS
Share on FacebookShare on Twitter

The Canadian mineral exploration company Apex Critical Metals saw its net loss expand significantly in its first fiscal quarter, ended October 2025. The loss quadrupled to CAD 2.68 million, a sharp increase from the CAD 0.4 million loss recorded in the same period the prior year. This substantial rise in expenditure is directly attributed to a major ramp-up in field activities across its North American projects, as the firm aggressively advances its exploration programs.

Financial Details and Funding

On a per-share basis, the loss widened from CAD 0.01 to CAD 0.05. Company leadership emphasized that this increase was driven by operational spending on exploration, not by higher administrative overhead. The capital was primarily deployed into a re-logging and re-sampling initiative at the Rift rare earths project in Nebraska, alongside summer field campaigns in Quebec and British Columbia.

Despite the increased burn rate, the company’s financial position was bolstered by a CAD 10 million financing round completed in October 2025. This injection is intended to sustain the accelerated operational pace. Cash reserves at the quarter’s end were reported at approximately CAD 5.86 million.

Significant Discovery in Quebec

A key operational highlight announced in mid-December 2025 was a notable discovery at Apex’s 100%-owned Lac Le Moyne project in Nunavik, Quebec. A recently concluded program, which involved collecting 151 rock samples, marked the first targeted exploration for carbonate-hosted mineralization on the property.

Should investors sell immediately? Or is it worth buying Apex Critical Metals?

The assay results surpassed expectations. Four samples returned values exceeding 0.20% Nb₂O₅ (niobium pentoxide), with a peak value of 0.40%. Furthermore, thirteen samples contained over 0.25% total rare earth oxides (REO), including a high-grade result of 0.50% REO. Encouraged by these findings, Apex has strategically staked an additional 77 claims, expanding its land position by roughly 3,609 hectares in the area.

Progress at the Rift Project and Auditor’s Note

In Nebraska, the company has completed the re-logging program at its Rift project. This work involved the modern re-analysis of historical drill cores originally extracted by Molycorp Inc. in the 1970s and 1980s. Assay results from this review are anticipated in the first quarter of 2026, to be followed by a phased drilling program scheduled to commence in early 2026.

On the corporate front, the company’s auditor included a going-concern note in late November 2025. This is a standard disclosure for junior exploration companies without revenue, highlighting their ongoing reliance on external financing to fund operations as a central investment risk.

Market Performance Context

Interestingly, the expanded quarterly losses have not dampened investor enthusiasm for the stock in the broader timeframe. Apex Critical Metals’ share price posted gains of over 100% during the 2025 calendar year. The company’s market capitalization sits between CAD 126 million and CAD 162 million. This market optimism appears to be fueled by the potential for the company’s exploration success to eventually define an economically viable resource. This prospect is set against a strategic backdrop of Western initiatives to secure independent supply chains for critical metals and reduce reliance on Chinese sources.

Ad

Apex Critical Metals Stock: Buy or Sell?! New Apex Critical Metals Analysis from February 7 delivers the answer:

The latest Apex Critical Metals figures speak for themselves: Urgent action needed for Apex Critical Metals investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Apex Critical Metals: Buy or sell? Read more here...

Tags: Apex Critical Metals
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Blue Ridge Bankshares Stock
Banking & Insurance

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

February 7, 2026
Next Post
Xiaomi Stock

Xiaomi's Premium Pivot: A High-Stakes Holiday Launch

Silber Preis Stock

Silver Shatters Records in Unprecedented Rally

Meta Stock

Meta's 2026 AI Roadmap Fuels Investor Confidence

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com